Integrity Applications Seeks FDA Approval

August 19, 2015 | The Israeli medical device company Integrity Applications has begun processes with the FDA to secure approval for its non-invasive glucose monitoring device. GlucoTrack monitors blood glucose levels with an ear-inserted device that then sends the data to a handheld device. Integrity Applications has already secured a CE Mark, as well as approval for use in other countries. The company will now begin clinical trials on the device for use in the US. Integrity Applications was founded by David Malka in 1999.